updates in cll: key clinical trials in the frontline and r/r setting, pre-clinical data and mrd
Published 2 years ago • 1.1K plays • Length 17:23Download video MP4
Download video MP3
Similar videos
-
2:35
the role of mrd in clinical decision-making in r/r cll
-
4:22
mrd monitoring in cll and clinical implications
-
1:29
the importance of treatment sequencing in cll
-
2:34
sequencing of therapies in patients with r/r cll
-
0:45
key trials in cll and designing a concept for treatment
-
35:30
cancer patient stories: getting diagnosed with leukemia (cll) | michele nadeem-baker
-
16:28
the latest in chronic lymphocytic leukemia (cll) treatments! | the patient story
-
5:00
venetoclax-obinutuzumab is superior to chemoimmunotherapy in frontline cll: updates from gaia/cll13
-
1:59
the role of mrd as a prognostic & predictive biomarker in cll
-
1:39
the growing role of mrd as a clinical endpoint in cll
-
10:25
oncogenic potentiol of hpv and its relation with cervical cancer
-
1:29
future research into mrd-guided treatment of cll
-
2:34
real-world data and mrd in cll
-
3:05
mrd assessment in cll
-
1:59
the expanding role of mrd in cll
-
7:55
clinical trials of fixed duration treatments & novel targets in cll
-
6:28
prognostic markers and mrd in cll
-
1:19
the prognostic value of mrd in cll
-
1:37
the importance of genomic testing in the diagnosis of cll
-
2:22
improve study: mrd assessment as an endpoint to define treatment length and intensity in cll
-
0:56
the current treatment landscape in cll
-
4:31
sequence of administration of ibrutinib with obinutuzumab in r/r cll patients